Published • loading... • Updated
Ebola Vaccine Trials Begin In DRC As Death Toll Nears 4,700
- The Democratic Republic of the Congo began the Tumaini Phase 2/3 trial in Bunia to test vaccines against the Bundibugyo Ebola virus.
- The outbreak has killed more than 4,600 people, with health authorities reporting 9,704 confirmed cases and 4,687 deaths by October 20.
- The trial will assess Ervebo and additional candidates from Moderna and the University of Oxford with the Serum Institute of India.
- Researchers will use ring vaccination to measure safety, immune responses, and effectiveness among people at high risk.
Insights by Ground AI
12 Articles
12 Articles
The worst episode of this disease in the history of the African country has exceeded 9,700 cases, with a number of deaths greater than 4,600.
·Warsaw, Poland
Read Full Article
Ebola Vaccine Trials Begin In DRC As Death Toll Nears 4,700
·Jersey City, United States
Read Full Article
Faced with the lack of an approved vaccine against the Bundibugyo strain, which is less common than the Zaire strain, the Democratic Republic of the Congo relies on several candidates, including Tumaini, to fight the deadly virus.
·Paris, France
Read Full Article
DRC begins new vaccine trial as outbreak kills over 4,600
The trial, named Tumaini, which means “hope” in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved The post DRC begins new vaccine trial as outbreak kills over 4,600 appeared first on Premium Times Nigeria.
·Abuja, Nigeria
Read Full Article
Ebola Vaccine Trial Begins in Congo With Three Shots in Sight
·New York, United States
Read Full Article
Coverage Details
Total News Sources12
Leaning Left3Leaning Right0Center3Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
